gms | German Medical Science

104th DOG Annual Meeting

21. - 24.09.2006, Berlin

European Vision Institute

Das European Vision Institute

Meeting Abstract

Search Medline for

  • E. Zrenner - Universitäts-Augenklinik, Eberhard-Karls-Universität Tübingen

Deutsche Ophthalmologische Gesellschaft e.V.. 104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft (DOG). Berlin, 21.-24.09.2006. Düsseldorf, Köln: German Medical Science; 2006. Doc06dogDO.17.02

The electronic version of this article is the complete one and can be found online at:

Published: September 18, 2006

© 2006 Zrenner.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



The European Vision Institute EEIG (‘EVI’; creates a new legal entity based on Community law to facilitate and encourage cross-border co-operation in Vision Research. Its major objectives are to conduct and support research, training, health information dissemination and other programs with respect to blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight and the special health problems and requirements of the blind and visually disabled. ‘EVI’ aims to foster centres in the EU in capacity building for innovative projects, to increase the flexibility, attractiveness and competitiveness of research careers, especially of young researchers. In a big step toward fulfilling this goal, ‘EVI’ successfully applied for an EU Integrated Project on retinal degeneration: ‘EVI-GENORET’, comprising 24 groups in 12 countries In addition, ‘EVI’ will improve and coordinate activities with patient organisations and build a pan-European platform for clinical trials. This platform has already been realized in the creation of EVI.CT.SE, a group of certified clinical trial sites across Europe